Status of the U.S. Endocrine Disruptor Screening Program (EDSP) Status of the U.S. Endocrine Disruptor Screening Program (EDSP) September 2009 1.

Slides:



Advertisements
Similar presentations
Health and Safety Executive Ecotoxicology Annex II and III data requirements Mark Clook Chemicals Regulation Directorate Health and Safety Executive UK.
Advertisements

1 Consumer Exposure Assessment at the U.S. Environmental Protection Agency: A ccomplishments and Opportunities for Global Collaboration Thomas Brennan.
Perspectives from EPA’s Endocrine Disruptor Screening Program
A Two-Tiered-Testing Decision Tree for Assays in the USEPA-EDSP Screening Battery: Using 15 years of experience to improve screening and testing for endocrine.
Evaluating Existing in vitro Endocrine Data Jeff Pregenzer, Director of Endocrine Studies, CeeTox.
UNEP Advisory Group Meeting Geneva, Switzerland December 12, 2014
Richard A. Becker, Ph.D., D.A.B.T American Chemistry Council Arlington, Virginia Comments on “Dose Setting” EDMVS Meeting July 23-24, 2002.
1 High Production Volume (HPV) Challenge Program Diane Sheridan Chief, Existing Chemicals Branch, Chemical Control Division, Office of Pollution Prevention.
Session III: Assessing Cumulative Effects of Endocrine Active Substances 9:15 - 9:30 Introduction” Rick Becker (Session Chair and Panel Moderator) 9:30.
TRICLOSAN : environmental exposure, toxicity and mechanisms of action Journal of Applied Toxicology 31: , 2011 Dann and Hontela Innovation Lectures.
1 High Production Volume (HPV) Challenge Program – Future Directions Jim Willis Director, Chemical Control Division, Office of Pollution Prevention and.
June 2010 LANDSIEDEL 1 Chemical Industries Role in Tomorrows Toxicity Testing Robert Landsiedel, Susanne Kolle, Tzutzuy Ramirez, Hennicke Kamp and Ben.
1 Office of Pesticide Programs Biopesticides and Pollution Prevention Division Sheryl K. Reilly, Ph.D. Chief, Biochemical Pesticides Branch
Priority-setting for the Endocrine Disruptor Screening Program: Pesticide Active Ingredients Penelope A. Fenner-Crisp Office of Pesticide Programs U.S.
National Pesticide Program A New Toxicology Testing Paradigm: Meeting Common Needs Steven Bradbury, Director Environmental Fate and Effects Division Office.
Endocrine Screening – Phase 1 TSCA 8(e) and FIFRA 6(a)(2) Requirements A. Michael Kaplan, Ph.D. December 13, 2010 A. Michael Kaplan & Associates, LLC
ISRTP 2009 Endocrine Workshop | 9-10 September 2009 | Washington, DC.
RTI International is a trade name of Research Triangle Institute The International Society of Regulatory Toxicology and Pharmacology (ISRTP)
EDSP Validation Gary E.Timm Senior Technical Advisor Office of Science Coordination and Policy U.S. Environmental Protection Agency.
Chemical Screening Programs Ted Smith Dale Phenicie.
Environmental Legislation & Regulations Professor Bernie Engel ASM 336 September 13, 2004.
WILLIAM JORDAN DEPUTY DIRECTOR, OFFICE OF PESTICIDE PROGRAMS UNITED STATES ENVIRONMENTAL PROTECTION AGENCY US EPA Regulation of Endocrine Disrupting Chemicals.
FDA’s Policy for Evaluating Bioengineered Foods Jeanette Glover Glew Food and Drug Administration Center For Food Safety and Applied Nutrition September,
Animal Feed GRAS Notifications Geoffrey K. Wong, M.S. Division of Animal Feeds Center for Veterinary Medicine Pet Food Institute Pet Food Institute October.
The Toxic Substances Control Act (TSCA) Interagency Testing Committee (ITC)
Criteria for Screens— Review of the EDSTAC Recommendations Presentation to the EDMVS July 23, 2002.
What Information Fulfills EDSP Screening Requirements?
The Role of Research in the Business of the Environmental Protection Agency Steven Bradbury, Director Environmental Fate & Effects Division Office of Pesticide.
Quill Law Group LLC1 EDSP Implementation Business and Legal Considerations Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
Quill Law Group LLC1 EDSP Compliance EDSP Phase 2 Policies and Procedures Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
Regulatory Controls PBT Strategy Team Great Lakes Regional Collaboration February 22, 2005.
EPA’s New Chemical List: Who, How, Possible Challenges & Responses, Listing Criteria Richard Becker, Ph.D., DABT American Chemistry Council December 13,
Office of Pesticide Programs 21st Century Screening Assessment of Pesticides – A Regulatory View Vicki Dellarco, Ph.D. Senior Science Advisor Office of.
Pesticide Regulatory Process
ARE 309Ted Feitshans08-1 Unit 13 Regulation of Pesticides Federal Insecticide, Fungicide and Rodenticide Act (FIFRA)
International Initiatives and the U.S. HPV Challenge Program Ken Geiser, PhD Lowell Center for Sustainable Production University of Massachusetts Lowell.
EDSP’s Approach to Test Protocol Validation Office of Science Coordination and Policy U.S. Environmental Protection Agency.
Quill Law Group LLC1 Endocrine Disruption and Personal Care Products --- Legislative Developments Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington,
Quill Law Group LLC1 EDSP Compliance Timing, Procedural and Legal Issues Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
Slide 1 of 24 EPA’s Endocrine Disruptor Screening Program (EDSP) Use of Exposure Data in Priority Setting Bill Wooge Office of Science Coordination and.
Atrazine By: Chris Nast APES 2 nd Hr.. Classification  Atrazine is a white, crystalline solid that is used as a synthetic herbicide to kill broadleaf.
1 Tier 1 EDSP: Other Scientifically Relevant Information Barbara Neal Exponent December 13, 2010.
ELLEN MIHAICH, PH.D., DABT ENVIRONMENTAL AND REGULATORY RESOURCES ISRTP WORKSHOP DECEMBER 13, 2010 EDSP Test Guidelines and Guideline Modifications 1.
Slide 1 of 30 Endocrine Disruptor Screening Program (EDSP); Policies and Procedures for Initial Screening International Society of Regulatory Toxicology.
Wildlife Screens What Do They Tell Us? Dr. Pat Guiney Manager Global Safety, Regulatory & Environmental Assessment S.C. Johnson & Son, Inc. Racine, WI.
Which information identifies a chemical as endocrine disrupting? Poul Bjerregaard Institute of Biology University of Southern Denmark Odense and Danish.
CALIFORNIA proposed SAFER CONSUMER PRODUCT REGULATIONS Marjorie MartzEmerson October 24, 2012.
Food Quality Protection Act of 1996 by: Bjorn Bookser period 2.
Regulatory Processes for Pesticides Mark Hartman Antimicrobials Division (AD) Office of Prevention, Pesticides and Toxic Substances United States Environmental.
International Society of Regulatory Toxicology and Pharmacology 2009 Endocrine Workshop The Endocrine Disruptor Screening Program: What Can Screening Results.
Potential Addition of Vapor Intrusion to the Hazard Ranking System U.S. EPA Office of Solid Waste and Emergency Response February 24, 2011 Listening Session.
Communications and the Endocrine Disruptor Screening Program ISRTP Workshop December 13, 2010.
Quill Law Group LLC1 EDSP Implementation Business and Legal Considerations Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
EDSP: T IER 1 T ESTING I NFORMATION C OLLECTION ISRTP 2010 Endocrine Workshop EDSP Compliance December 13, 2010 Susan Ferenc, DVM, Ph.D.
Introduction to Session II: Incorporating Existing Data into the EDSP Erik R. Janus Director, Human Health Policy CropLife America.
By Michelle Hoang Period 2 APES April 30, 2012 The Toxic Substances Control Act of 1976.
Industry Perspective on TSCA Modernization ABA Conference June 11, 2010.
EDSP Implementation: Concerns for the Pesticide Industry ISRTP 2009 Endocrine Workshop: The Endocrine Disruptor Screening Program: What Can Screening Results.
UNIT 9 Hazardous Wastes and Risk Assessment. Major Public Agencies Involved in Environmental Health Risk Assessment and Intervention Consumer Product.
Endocrine Disruptor Screening and Testing: An Industry Update
Safe Drinking Water Act , CCL and Perchlorate
Update on recent developments in the ed regulatory landscape in Europe
Food Quality Protection Act of 1996
Richard Becker, Ph.D., DABT American Chemistry Council
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
Comments on Using Existing Data for the Endocrine Screening Testing Lorenz Rhomberg, PhD Principal Gradient ISRTP 2009 Endocrine Workshop.
Mammalian Tier I EDSP Screening Assays: What do they tell us?
International Initiatives and the U.S. HPV Challenge Program
FQPA: “It’s a Good Thing” (for Kids)
Presentation transcript:

Status of the U.S. Endocrine Disruptor Screening Program (EDSP) Status of the U.S. Endocrine Disruptor Screening Program (EDSP) September

EPA’s Statutory Authority Federal Food, Drug, and Cosmetic Act (FFDCA) Federal Food, Drug, and Cosmetic Act (FFDCA) Requires EPA to: Requires EPA to: Develop a screening program using validated assays to identify chemicals that may have estrogenic effects in humans Develop a screening program using validated assays to identify chemicals that may have estrogenic effects in humans Test all pesticide chemicals (both active and inert ingredients) Test all pesticide chemicals (both active and inert ingredients) Authorizes EPA to obtain testing on: Authorizes EPA to obtain testing on: Other endocrine effects, as designated by the EPA Administrator (e.g., androgen and thyroid; endocrine effects in species other than humans) Other endocrine effects, as designated by the EPA Administrator (e.g., androgen and thyroid; endocrine effects in species other than humans) Other chemicals (non-pesticides) that: Other chemicals (non-pesticides) that: May have “an effect cumulative to that of a pesticide,” if a “substantial human population may be exposed” to the chemical May have “an effect cumulative to that of a pesticide,” if a “substantial human population may be exposed” to the chemical Safe Drinking Water Act (SDWA) Amendments Safe Drinking Water Act (SDWA) Amendments Allow EPA to require testing of chemical substances that may be found in sources of drinking water, if a substantial human population may be exposed to the substance Allow EPA to require testing of chemical substances that may be found in sources of drinking water, if a substantial human population may be exposed to the substance 2

EDSP Scope and Structure Established following recommendations of : The Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) of Estrogen, androgen and thyroid Estrogen, androgen and thyroid Human health, fish and wildlife Human health, fish and wildlife Pesticides, commercial chemicals, environmental contaminants Pesticides, commercial chemicals, environmental contaminants 3

EDSP Scope and Structure Two-Tiered Approach Two-Tiered Approach Tier 1 Tier 1 In vitro and in vivo screens In vitro and in vivo screens Detect potential to interact with endocrine system Detect potential to interact with endocrine system Tier 2 Tier 2 Tier 2 data called in only after review of Tier 1 data Tier 2 data called in only after review of Tier 1 data Multi-generation studies covering a broad range of taxa Multi-generation studies covering a broad range of taxa Provide data for hazard assessment Provide data for hazard assessment 4

Priority Setting Assay Validation Procedures EDSP Implementation  Assay Validation Development and validation of test assays Tier 1 screening & Tier 2 testing  Priority Setting Selecting chemicals to be screened  Procedures Developing procedures to require and administer EDSP data 5

Proposed EDSP Tier 1 Screening Battery In vitro Estrogen receptor (ER) binding – rat uterus Estrogen receptor α (hERα) transcriptional activation - Human cell line (HeLa-9903) [OECD Test Guideline 455] Androgen receptor (AR) binding – rat prostate Steroidogenesis – Human cell line (H295R) [US lead, validated in OECD program] Aromatase – Human recombinant In vivo Uterotrophic (rat) [OECD TG 440] Hershberger (rat) [OECD TG 441] Pubertal female (rat) Pubertal male (rat) Amphibian metamorphosis (frog) [OECD TG 231] Fish short-term reproduction [OECD TG 229] 6

Tier 2 Tests Mammalian two-generation rat (may be replaced by Extended F1-Generation) Avian reproduction (Japanese quail) [US lead, OECD validation program] Amphibian growth/reproduction (Xenopus) [US lead, OECD validation program] Fish life-cycle (medaka) [US lead, OECD validation program] Mysid life-cycle [US lead, OECD validation program]

SAP Battery Review Conclusions Chemicals testing positive in the battery of Tier 1 assays would be identified as potential estrogenic, androgenic and thyroid hormone active substances The ability to identify endocrine active substances is enhanced in the Tier 1 battery because the tests provide adequate replication and redundancy It was clear that the inclusion of apical assays of amphibian metamorphosis and fish short-term reproduction were important to detect endocrine active substances that may operate by mechanisms of action yet to be discovered The 15-day adult male assay proposed during some public comments would not be an appropriate substitute for the male and female pubertal assays because the pubertal assays provide for differences between the sexes and provide the only approach to testing for organizational- effects during development.

SAP Battery Review Recommendations Assays for ERß Assays for ERß Monitor only first estrus cycle Monitor only first estrus cycle Need validated ER antagonist assay Need validated ER antagonist assay Replace cytosolic assays with recombinant Replace cytosolic assays with recombinant Validate AR transactivation assay Validate AR transactivation assay Include perinatal developmental endpoints in Tier 1 if possible Include perinatal developmental endpoints in Tier 1 if possible Develop standardized procedures for hormone measurement Develop standardized procedures for hormone measurement Need to demonstrate a negative control in the pubertal assays Need to demonstrate a negative control in the pubertal assays Need new tests and endpoints for thyroid in Tier 1 Need new tests and endpoints for thyroid in Tier 1 New assay systems will be required for novel EAT mechanisms and other hormones New assay systems will be required for novel EAT mechanisms and other hormones

Priority Setting: First Chemicals to be Screened Issued the Final List of Chemicals for Initial Screening 15 April 2009 Issued the Final List of Chemicals for Initial Screening 15 April Pesticide actives 64 Pesticide actives 9 High ProductionVolume / pesticide inerts 9 High ProductionVolume / pesticide inerts Selection based on potential human exposure Selection based on potential human exposure Pesticide Active Ingredients: presence in food and water, residential use, and occupational contact Pesticide Active Ingredients: presence in food and water, residential use, and occupational contact HPV inerts in human and eco biomonitoring, water, air HPV inerts in human and eco biomonitoring, water, air Selected chemicals found in multiple exposure pathways. Selected chemicals found in multiple exposure pathways. Not a list of “known” or “likely” endocrine disruptors Not a list of “known” or “likely” endocrine disruptors 10

Policies & Procedures Orders EPA Intends to Issue Test Orders/DCIs EPA Intends to Issue Test Orders/DCIs Under FFDCA §408(p)(5) Under FFDCA §408(p)(5) Under FIFRA §3(c)(2)(B) Under FIFRA §3(c)(2)(B) Two Types of Orders (based on recipient) Two Types of Orders (based on recipient) Manufacturers and Importers Manufacturers and Importers Pesticide Registrants Pesticide Registrants 11

Test Orders Approximately 750 test orders will be issued for 67 chemicals. Approximately 750 test orders will be issued for 67 chemicals. Currently, EPA anticipates issuing test orders over several months period. Currently, EPA anticipates issuing test orders over several months period. Test Orders for chemicals will require all the assays in the Tier 1 battery. Test Orders for chemicals will require all the assays in the Tier 1 battery. Responses to Test Orders due 90 days from receipt Responses to Test Orders due 90 days from receipt Test data due 24 months from issuance of Test Order Test data due 24 months from issuance of Test Order 12

Possible Responses to Test Orders 1. I will generate new data. 2. I am citing existing data. 3. I am entering into an agreement to form a consortium to provide the data. 4. I am not subject to the Test Order. 5. I intend to voluntarily cancel the pesticide registration. 6. I intend to reformulate the product(s) to exclude this chemical from the formulation. 7. I am claiming a formulators’ exemption. 8. I have/am in the process of discontinuing the manufacture/import of this chemical. 9. I do not and will not sell my chemical for use as an inert ingredient to the pesticide market. 13

Next Steps Clearance of the Information Collection Request Clearance of the Information Collection Request Posting of final Test Method Protocols Posting of final Test Method Protocols Publication of final notice of Tier 1 Screening Battery Publication of final notice of Tier 1 Screening Battery Issuance of Test Orders Issuance of Test Orders Receipt of Responses Receipt of Responses Notification of Agency Decisions Notification of Agency Decisions 14

EDSP Timeline Proposed Chemical Selection Strategy Tier I Validation Tier II Development and Validation Development of Procedural Framework Initial List Final Tier I Screening Draft Initial List …